Our goal as developers of advanced neurotechnologies is first and foremost to help those who are suffering from neurological diseases. Given our experience in epilepsy, Carbon Cybernetics is focused on ultra-small accuracy seizure monitoring devices that can apply interventions to stop seizures before they start.
Carbon Cybernetics was born at the University of Melbourne in Prof. David Garrett’s Carbon Biomaterials research group and Prof. Steven Prawer’s Advanced Carbon Materials research program. As a part of this large team, Dr. Nick Apollo and Dr. Matias Maturana collaborated to develop neural interfacing electrodes built from graphene, carbon nanotubes, and other carbon-based nano-materials.
The high performance and soft, flexible nature of these electrodes made them ideal candidates for implementation into a robust, chronically-implanted electrode array built to last a lifetime.
Meet the Board
A/Prof. David Garrett
Associate Professor David J. Garrett is an internationally regarded research scientist invested in developing high performance electrodes for use inside the body. He holds an Australian Research Council Future Fellowship award and leads a research group at RMIT University. David has ten years of innovation in medical device technology, particularly in novel materials for neural interface applications.
Dr Matias Maturana
Matias completed his PhD in Electrical Engineering. His research focused on the electrical stimulation of neurons. As a postdoc, Matias worked on a clinical trial of deep brain stimulation for epilepsy using a special research device capable of recording brain activity. His research focus is in seizure prediction and management.
Dr. Nick Apollo
Nick completed his bachelor’s degree in biomedical engineering and PhD in physics. He was previously an NIH Training Fellow in Neurotechnology at the University of Pennsylvania. Currently, he works as a Sr. Scientist and Sensor Engineer in the continuous glucose monitoring industry. His research interests include microfabrication, electrochemistry, and materials science.
Prof. Jim Patrick AO
Former Chief Scientist of Cochlear Australia
Jim was a member of Professor Graeme Clark’s original Cochlear Implant Research Team (1975 – 1981) at the University of Melbourne, Australia, which invented the world’s first multichannel cochlear implant. In 1981, he was a founding member of Cochlear Limited, which is now the global leader in implantable hearing solutions. During his time at Cochlear Australia he served in a variety of roles, ultimately as Chief Scientist. Jim received the Order of Australia in 2015 for distinguished service to science.
Prof. Mark Cook
Neurologist, Epileptologist, St Vincent’s Hospital, Melbourne
Former CFO of Cochlear Ltd.
Brent has over 35 years experience, with the majority in CFO roles across a broad range of industries Health (Cochlear, Home Doctor, Fitness First), NFP (Cancer Hospital), Media (Nine Entertainment/ ACP Magazines), Property (Westfield, Sheraton) in both public and PE owned companies. He was the CFO for Cochlear (ASX:COH) from early 2017 until late 2020 and is currently an advisor to an Australian technology company. Brent Qualified as a Chartered Accountant with Deloitte and he has been a Director for various charities.
Meet the Team
Prof. Steven Prawer
Professor Prawer is a world leader in diamond science and technology, has published over 410 journal papers and in 2010 was elected to the Australian Academy of Science. He has a long history of successful leadership in large multidisciplinary projects including the High-Acuity Arm of Bionics Vision Australia where he commercialised novel diamond devices for retinal implant technology. He also spearheaded the University of Melbourne’s entry into the world of quantum computing and co-founded Quantum Communications Victoria which produced the first commercial prototype of a single photon source.
Curious to know more?
Get in touch with us today and ask about our new seizure forecasting technology.